Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis

Clinical trial NCT01982942 · COMPLETED

Trial details

NCT number: NCT01982942
Sponsor: MediciNova
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Secondary Progressive

Start date: 2013-11-01
Primary completion: 2017-05-01
Enrollment: 255

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.